Dr. Seltzer, president and founder of ACI Clinical, and chief scientific officer of WCG Clinical, shared his insights on expert committees during a recent conversation with Bill Stedman, manager, member services, ACI Clinical.
Other content in this Stream
Preparing for Success: A Better Way to Manage the Feasibility Process
A maturity model for site feasibility.
Quiz: The State of the Site Selection & Feasibility Industry
Chances are there are improvements you could be making to your study startup process. But, how much do you know about the challenges the entire industry also faces? Take this short quiz to find out.
32:54Reinventing Site Feasibility: Moving from Simple Survey to Relationship Management
Best Practices in Site Feasibility Studies Can Set the Stage for a Healthy Trial
Well-performed, confident site feasibility studies, at times a tedious, thankless task, can become the single most important factor in reducing costs and time spent during a clinical trial...
1:00:28Unlocking the Full Potential of Your Patient Recruitment ROI
<p>WCG Institute Fellow, Mark Summers, WCG's President of Patient Engagement, discusses best practices for forecasting patient enrollment through the Concentric Circle Framework. This is part one of a
1:00:21Solving The Problem of Clinical Research Enrollment
Examine the conditions that affect enrollment and learn strategies to increase it.
Six Practices of High Performing Clinical Research Sites
Learn what high-performing research sites have in common, and what makes sponsors return to them again and again.
Finding New Solutions to a Current Unsustainable Model of Clinical Trial Contracts & Budgets
13:58The Role of Expert Committees: An interview with Dr. Seltzer
What’s the role of expert committees today? What’s happening on the regulatory side? Dr. Seltzer, Chief Scientific Officer of WCG Clinical, shared his insights on expert committees during a recent...
Centralized adjudication of cardiovascular end points in cardiovascular and noncardiovascular pharrmacologic trials